Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11418133 | 1.00 | CYP2C19 (0.37) | CYP2C19FFAR3AKR1C1NPSR1USP2 | |
| SCHEMBL10788998 | 0.82 | CYP2C19 (0.37) | CYP2C19FFAR3AKR1C1NPSR1USP2 | |
| SCHEMBL10520322 | 0.78 | CYP2C19 (0.34) | CYP2C19FFAR3AKR1C1 | |
| SCHEMBL19056401 | 0.78 | FFAR3 (0.39) | CYP2C19FFAR3NPSR1LMNABLM | |
| SCHEMBL27450113 | 0.77 | TSHR (0.39) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL28498843 | 0.73 | CYP2C19 (0.32) | CYP2C19FFAR3 | |
| SCHEMBL2772996 | 0.72 | FFAR3 (0.32) | CYP2C19FFAR3 | |
| SCHEMBL23245204 | 0.65 | CYP2C19 (0.42) | CYP2C19FFAR3AKR1C1NPSR1USP2 | |
| Hydrochloric Acid SCHEMBL4461485 | 0.65 | CYP2C19 (0.42) | CYP2C19FFAR3AKR1C1NPSR1USP2 | |
| SCHEMBL11208917 | 0.65 | CYP2C19 (0.42) | CYP2C19FFAR3AKR1C1NPSR1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3392036-B1 | METHOD FOR PRODUCING LAMINATE, AND LAMINATE | KANEKA CORP (JP) | 2022-03-30 | — | — | EP | claimed |
| US-10836739-B2 | Epoxycyclohexane dicarboxylic acid diester, plasticizer, stabilizer and resin composition | NEW JAPAN CHEMICAL CO., LTD (JP) | 2020-11-17 | — | — | US | claimed |
| EP-3392036-A1 | METHOD FOR PRODUCING LAMINATE, AND LAMINATE | Kaneka Corporation (JP) | 2018-10-24 | — | — | EP | claimed |
| CN-108367547-A | The manufacturing method and laminated body of laminated body | 株式会社钟化 | 2018-08-03 | — | — | CN | claimed |
| US-20180127390-A1 | EPOXYCYCLOHEXANE DICARBOXYLIC ACID DIESTER, PLASTICIZER, STABILIZER AND RESIN COMPOSITION | NEW JAPAN CHEMICAL CO., LTD (JP) | 2018-05-10 | — | — | US | claimed |
| US-9963601-B2 | Photocationically curable ink jet ink, method of manufacturing photocationically curable ink jet ink, printed matter, and method of manufacturing printed matter | TOKYO PRINTING INK MFG. CO., LTD. (JP) | 2018-05-08 | — | — | US | claimed |
| EP-3305772-A1 | EPOXYCYCLOHEXANE DICARBOXYLIC ACID DIESTER, PLASTICIZER, STABILIZER AND RESIN COMPOSITION | New Japan Chemical Co., Ltd. (JP) | 2018-04-11 | — | — | EP | claimed |
| US-20160257828-A1 | PHOTOCATIONICALLY CURABLE INK JET INK, METHOD OF MANUFACTURING PHOTOCATIONICALLY CURABLE INK JET INK, PRINTED MATTER, AND METHOD OF MANUFACTURING PRINTED MATTER | TOKYO PRINTING INK MFG. CO., LTD. (JP) | 2016-09-08 | — | — | US | claimed |
| EP-3056551-A1 | PHOTOCATIONIC CURABLE INKJET INK, PRODUCTION METHOD FOR PHOTOCATIONIC CURABLE INKJET INK, PRINTED ARTICLE, AND PRODUCTION METHOD FOR PRINTED ARTICLE | Tokyo Printing Ink Mfg. Co. Ltd. (JP) | 2016-08-17 | — | — | EP | claimed |
| JP-61004748-A | — | — | None | — | — | JP | disclosed |
| JP-58222136-A | — | — | None | — | — | JP | disclosed |
| JP-59113014-A | — | — | None | — | — | JP | disclosed |
| US-12043775-B2 | Adhesive film | RIKEN TECHNOS CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| CN-118325041-A | Curable composition, method for producing cured product, and cured product thereof | 株式会社ADEKA | 2024-07-12 | — | — | CN | disclosed |
| EP-0189899-A2 | Synthetic resin composition having reduced corrosion-causing tendency and coloration | Kyowa Chemical Industry Co., Ltd. (JP) | 1986-08-06 | — | — | EP | disclosed |
| JP-S614748-A | VINYL CHLORIDE RESIN COMPOSITION | TERUMO CORP | 1986-01-10 | — | — | JP | disclosed |
| JP-S59113014-A | MOLD RELEASABLE RESIN AND MOLD RELEASABLE RESIN COMPOSITION | SUMITOMO BAKELITE CO LTD | 1984-06-29 | — | — | JP | disclosed |
| JP-S58222136-A | COMPOSITION OF VINYL CHLORIDE RESIN HAVING HIGH DEGREE OF POLYMERIZATION | NEW JAPAN CHEM CO LTD | 1983-12-23 | — | — | JP | disclosed |
| US-4288488-A | Laminated packing material with a high gas-impermeablility and an advantageous workability | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1981-09-08 | — | — | US | disclosed |
| US-4117029-A | VINYL CHLORIDE POLYE | NITTO KASEI CO. LTD. (JP) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10836739-B2 | Epoxycyclohexane dicarboxylic acid diester, plasticizer, stabilizer and resin composition | CECR2, DCLRE1A, DDT | CYP2C19 2754/4885FFAR3 1413/4885AKR1C1 822/4885 |
| US-20180127390-A1 | EPOXYCYCLOHEXANE DICARBOXYLIC ACID DIESTER, PLASTICIZER, STABILIZER AND RESIN COMPOSITION | CECR2, DCLRE1A, DDT | CYP2C19 2754/4885FFAR3 1413/4885AKR1C1 822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.